首页> 外文期刊>Applied immunohistochemistry and molecular morphology: AIMM >Assessment of Bone Marrow Microvessel Densityin Chronic Lymphocytic Leukemia
【24h】

Assessment of Bone Marrow Microvessel Densityin Chronic Lymphocytic Leukemia

机译:慢性淋巴细胞白血病的骨髓微血管密度评估

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Angiogenesis is a physiologic process of new bloodvessels formation mediated by various cytokines called pro-angiogenic and antiangiogenic factors. Enhancement of angio-genesis in chronic lymphocytic leukemia (CLL) has beenrecognized more recently. Our study assesses CD34 and vonWillebrand factor (vWf) expression and microvessel density(MVD) in the bone marrow of patients with CLL. Aims: (1) To assess bone marrow MVD in CLL using 2 differentmonoclonal antibodies, CD34 and vWf; and (2) To examine thepossible association of marrow MVD and clinical course,pattern of marrow infiltration, Rai stage, CD38 positivity, andcytogenetic abnormalities detected by fluorescence in situhybridization. Materials and Methods: Bone marrow specimens from 33patients with CLL and 10 controls were studied. A singlemicrovessel was defined as any vessel with a clear lumen. Thescreening of the slides was carried out by hotspot method. Theslides were initially screened at low power to identify the areaswith highest number of microvessel or vascularity hotspot. Thecount of microvessel in a sufficiently extended field (40 xobjective lens, 10 x ocular lens) was then performed. The meanvalue of 10 most vascularized areas at 400 x field wasconsidered as MVD for a sample. Results: There was a significant difference between MVD countsaccording to the antibody used. MVD was higher using CD34versus vWF (CD34: mean +- SD, 35.91 +- 15.7; 95% confidenceinterval of mean, 30.34-41.48 vessels/field versus vWF:8.15 +-4.65; 95% confidence interval of mean, 4.11-12.44vessels/field; P < 0.0001]. Bone marrow MVD detected byCD34 was significantly higher in patients with CD38 expressionmore than 30% (P = 0.006) and in patients with unfavorablecytogenetic abnormalities. However, no significant MVDdifferences were detected between CLL subgroups with regardto clinical course, pattern of marrow infiltration, and Rai stage.Bone marrow MVD in patients with CLL was significantlyhigher than that in contro...
机译:简介:血管生成是由称为促血管生成和抗血管生成因子的各种细胞因子介导的新血管形成的生理过程。最近已经认识到慢性淋巴细胞白血病(CLL)中血管生成的增强。我们的研究评估了CLL患者骨髓中CD34和vonWillebrand因子(vWf)的表达以及微血管密度(MVD)。目的:(1)使用两种不同的单克隆抗体CD34和vWf评估CLL中的骨髓MVD; (2)探讨荧光原位杂交技术检测骨髓MVD与临床病程,骨髓浸润模式,Rai分期,CD38阳性以及细胞遗传学异常的可能联系。材料与方法:研究了33位CLL患者和10位对照的骨髓标本。单个微血管定义为具有透明管腔的任何血管。载玻片的筛选通过热点法进行。首先以低功率筛选这些幻灯片,以识别微血管或血管热点数量最多的区域。然后在足够扩展的视野(40个物镜,10个目镜)中进行微血管计数。将在400 x视野处的10个最血管化区域的平均值视为样品的MVD。结果:根据所使用的抗体,MVD计数之间存在显着差异。使用CD34与vWF相比,MVD更高(CD34:平均值+-SD,35.91 +/- 15.7; 95%的平均值置信区间为30.34-41.48血管/视野,而vWF:8.15 + -4.65; 95%的平均值置信区间为4.11-12.44血管/ field; P <0.0001]。CD34表达超过30%的患者和不良细胞遗传学异常患者中CD34检测到的骨髓MVD显着较高,但是在临床过程中CLL亚组之间未检测到明显的MVD差异。 ,骨髓浸润的模式和Rai分期.CLL患者的骨髓MVD明显高于对照组。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号